CDCA5 PEPTIDES AND VACCINES CONTAINING THE SAME

WIPO Patent Application WO/2014/106886

A1

Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides derived from the CDCA5 that elicit CTLs and thus are suitable for use in the context of cancer immunotherapy are provided. Further provided are polynucleotides encoding such peptides as well as pharmaceutical compositions that include any such peptides or polynucleotides as active agents. Antigen-presenting cells with CTL inducibility and CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. Furthermore, the present invention provides methods for the treatment and/or prophylaxis (i.e., prevention) of cancers (tumors), and/or the prevention of a metastatic or postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the epitope peptides derived from CDCA5, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention.

TSUNODA TAKUYA (JP)
OSAWA RYUJI (JP)
YOSHIMURA SACHIKO (JP)
WATANABE TOMOHISA (JP)

PCT/JP2013/007678

July 10, 2014

December 27, 2013

Click for automatic bibliography generation  

ONCOTHERAPY SCIENCE INC (JP)

C12N15/09; A61K31/7088; A61K35/17; A61K35/26; A61K39/00; A61P35/00; C07K7/06; C12N1/15; C12N1/19; C12N1/21; C12N5/10

WO2011125334A1	2011-10-13
WO2009028581A1	2009-03-05

HARUNA, Masao et al. (1-1-1 Oroshi-machi, Tsuchiura-sh, Ibaraki 47, JP)

View/Download PDF      PDF Help

Previous Patent: AXIAL FLOW BLOOD PUMP

Next Patent: SECONDARY-CELL METAL TERMINAL COATING RESIN FILM, METHOD FOR MANUFACTURING SAME, AND CELL PACK